<?xml version="1.0" encoding="UTF-8"?>
<p>The (AJ) EO was evaluated against COX enzymes, and its activity was compared with the positive control, the commercial NSAID Ketoprofen. In two concentrations 50 and 350 Âµg/mL, the percentage inhibition of COX-1 and COX-2 increased with an increase in the concentration of EO used as presented in 
 <xref ref-type="fig" rid="molecules-26-02831-f007">Figure 7</xref>. The (AJ) EO showed potential inhibitory activity towards COX-1 and COX-2 enzymes as presented in 
 <xref rid="molecules-26-02831-t004" ref-type="table">Table 4</xref>.
</p>
